Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Zentiva“
Suchtreffer
Begriffe & Kennungen
Clopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.5 · Medicinal products that are strong or moderate CYP2C19 inhibitors include, for example, omeprazole and esomepr
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.5 · NSAIDs In a clinical study conducted in healthy volunteers, the concomitant administration of clopidogrel and
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.5 · Oral anticoagulants The concomitant administration of clopidogrel with oral anticoagulants is not recommended
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.5 · Other concomitant therapy Inducers of CYP2C19 Since clopidogrel is metabolised to its active metabolite partly
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.5 · Other medicinal products A number of other clinical studies have been conducted with clopidogrel and other con
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.5 · Proton Pump Inhibitors (PPI) Omeprazole 80 mg once daily administered either at the same time as clopidogrel o
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.5 · Rifampicin strongly induces CYP2C19, resulting in both an increased level of clopidogrel active metabolite and
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.5 · SSRIs Since SSRIs affect platelet activation and increase the risk of bleeding, the concomitant administration
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.5 · The pharmacokinetics of digoxin or theophylline were not modified by the co-administration of clopidogrel. Ant
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.5 · There is no evidence that other medicinal products that reduce stomach acid such as H2 blockers or antacids in
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.5 · Thrombolytics The safety of the concomitant administration of clopidogrel, fibrin or non-fibrin specific throm
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.8 Undesirable effects · 1
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.8 · 10 System Organ Common Uncommon Rare Very rare, not Class known* Immune system Serum sickness, disorders anaph
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.8 · 11 System Organ Common Uncommon Rare Very rare, not Class known* Gastrointestinal Gastrointestinal Gastric ulc
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.8 · 12 Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the m
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.8 · Bleeding is the most common reaction reported both in clinical studies as well as in post-marketing experience
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.8 · In ACTIVE-A, the rate of major bleeding was greater in the clopidogrel + ASA group than in the placebo + ASA g
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.8 · In CLARITY, there was an overall increase in bleeding in the clopidogrel plus ASA group vs. the placebo plus A
Eintrag öffnen